These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28851171)

  • 21. Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles.
    Bourgain C; Smitz J; Camus M; Erard P; Devroey P; Van Steirteghem AC; Kloppel G
    Hum Reprod; 1994 Jan; 9(1):32-40. PubMed ID: 8195348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Day two post retrieval 1500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger - a proof of concept study.
    Vanetik S; Segal L; Breizman T; Kol S
    Gynecol Endocrinol; 2018 Feb; 34(2):132-135. PubMed ID: 28933569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2005 Jul; 20(7):1798-804. PubMed ID: 15890740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of luteal phase defects with pulsatile infusion of gonadotropin-releasing hormone.
    Loucopoulos A; Ferin M
    Fertil Steril; 1987 Dec; 48(6):933-6. PubMed ID: 3119374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity.
    Devroey P; Bourgain C; Macklon NS; Fauser BC
    Trends Endocrinol Metab; 2004 Mar; 15(2):84-90. PubMed ID: 15036255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
    Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
    Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors.
    Develioglu OH; Hsiu JG; Nikas G; Toner JP; Oehninger S; Jones HW
    Fertil Steril; 1999 Jun; 71(6):1040-7. PubMed ID: 10360907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1985 Sep; 117(3):1043-9. PubMed ID: 3893990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteal phase support in assisted reproductive technology.
    Pabuccu R; Akar ME
    Curr Opin Obstet Gynecol; 2005 Jun; 17(3):277-81. PubMed ID: 15870562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment.
    Massai MR; de Ziegler D; Lesobre V; Bergeron C; Frydman R; Bouchard P
    Fertil Steril; 1993 Jun; 59(6):1179-86. PubMed ID: 8495762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the development of uterine pinopodes in steroid hormone supplemented cycles.
    Oborná I; Novotný R; Brezinová J; Petrová P; Lichnovský V; Fingerová H
    Physiol Res; 2004; 53(4):423-9. PubMed ID: 15312002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.